I am looking to double my investment on Monday, but when reading that the closing of this agreement with Novartis is subject to FTC and DOJ approval, I think of the injustice that the FDA has dealt us of recent and wonder are these agencies manipulated and controlled by the the same influences that the FDA seemed to be under. If so doubling down may prove to be hasty, that is why I would like the thoughts of other investors of MSB prior to Mondays opening.
Howie
Hart-Scott-Rodino Antitrust Improvements Act, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.015(1.53%) |
Mkt cap ! $1.150B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 99.0¢ | $4.221M | 4.206M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 54428 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 24734 | 6 |
View Market Depth
| Last trade - 15.02pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |